Zynerba Pharmaceuticals (ZYNE)

[Leonard McKinley]

You do realize, I expect, that GWPH has a $4.5 Billion market cap with only one product for two fairly rare epilepsies. Every one of the four indications which Zyne is targeting is much, much larger than GWPH's indication. Now, mind you, I think GWPH is significantly over valued. That may come from having been first, but it is sometimes said that being second can be much better than being first because it allows one to observe the errors of being first. I think GWPH will get smaller, and Zyne will get much, much bigger.

President William McKinley was my first cousin, thrice removed. That just means that he was a first cousin to my great great grandfather. The President had no direct descendants.